Drug Discovery on Your Doorstep

Keeping your oncology drug development in one location is a complex priority, but it doesn’t need to be a complex journey.

With a full suite of cutting-edge services at Crown Bioscience UK, together with our broader European operations, we remove the location and time zone hurdles so you can make faster, actionable, and more predictive decisions.

Our specialist oncology services cover advanced in vivo imaging platforms including BLI, HF-ultrasound, and CT. We also establish orthotopic models via ultrasound, which provide a clinically-relevant, organ-specific TME to improve preclinical predictivity over subcutaneous alternatives. Our growing collection of luciferase-labeled validated in vivo models allow you to non-invasively monitor the longitudinal growth of a tumor and to track tumor response to your treatment in real time.

In choosing our facility, you benefit from our strict adherence to UK animal welfare regulations, some of the most stringent globally. We also offers hassle-free logistics, so you can avoid the increasing biosecurity challenges of global material shipments, simplify processes, and ensure your research materials and results stay closer to you.